These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2080622)

  • 21. [Long-term therapy with benzbromarone in uric arthritis].
    Bröll H; Sochor H; Tausch G; Eberl R
    Wien Med Wochenschr; 1975 Sep; 125(28):546-8. PubMed ID: 816095
    [No Abstract]   [Full Text] [Related]  

  • 22. [Results obtained with long-term benzbromarone therapy (author's transl)].
    Bresnik W; Müller MM
    Wien Klin Wochenschr; 1974 May; 86(10):283-7. PubMed ID: 4428763
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipid disorders in gout and in hyperuricemia with myalgia].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Mars Med; 1972; 109(10):609-25. PubMed ID: 4659841
    [No Abstract]   [Full Text] [Related]  

  • 24. [Allomaron in hyperuricemia and gout].
    Barsom S
    ZFA (Stuttgart); 1979 Aug; 55(24):1336-40. PubMed ID: 539082
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro.
    Inokuchi T; Tsutsumi Z; Takahashi S; Ka T; Yamamoto A; Moriwaki Y; Masuzaki H; Yamamoto T
    Horm Metab Res; 2009 Apr; 41(4):327-32. PubMed ID: 19048458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects and side effects of benzbromaron in the initial treatment of hyperuricemia and gout. Results of a field study on 3899 patients].
    Matzkies F
    Fortschr Med; 1978 Aug; 96(32):1619-21. PubMed ID: 680625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ten years' experience with benzbromarone in the management of gout and hyperuricaemia.
    Masbernard A; Giudicelli CP
    S Afr Med J; 1981 May; 59(20):701-6. PubMed ID: 7221794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP
    Fortschr Med; 1983 May; 101(18):851-3. PubMed ID: 6862346
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lipid disorders in gout and hyperuricemias].
    Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
    Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):95-105. PubMed ID: 4705340
    [No Abstract]   [Full Text] [Related]  

  • 30. Relationship between serum allantoin and urate in healthy subjects and effects of benzbromarone in gout patients.
    Kurajoh M; Koyama H; Shoji T; Sumida C; Yamamoto A; Tsutsumi Z; Moriwaki Y; Yamamoto T; Koga M
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):265-71. PubMed ID: 22456297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels].
    Perova NV; Ozerova IN; Kalinina AM; Pavlova LI; Olfer'ev AM; Mel'kina OE; Golubev MA; Oganov RG
    Ter Arkh; 1996; 68(1):71-6. PubMed ID: 8644040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid studies in primary gout.
    Yu TF; Oreskes I
    Mt Sinai J Med; 1989 Jan; 56(1):11-6. PubMed ID: 2784177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1970 Jan; 82(5):78-82. PubMed ID: 5513199
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of spironolactone and thiabutazide on serum-uric acid and lipid levels in patients with gout and in healthy persons].
    Mertz DP
    Dtsch Med Wochenschr; 1973 Jan; 98(1):11-5. PubMed ID: 4684940
    [No Abstract]   [Full Text] [Related]  

  • 35. Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.
    Cardona F; Tinahones FJ; Collantes E; Escudero A; García-Fuentes E; Soriguer FJ
    Ann Rheum Dis; 2005 Jan; 64(1):85-8. PubMed ID: 15115711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease-specific noncompliance with drug treatment as a cause of persistent hyperuricemia and gout in anorexia nervosa.
    Gröbner W; Walter-Sack I; de Vries JX
    Eur J Med Res; 1998 Feb; 3(1-2):77-80. PubMed ID: 9512972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
    Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
    Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treating gout with benzbromarone (author's transl)].
    Bosmanský K; Trnavský K
    Cas Lek Cesk; 1979 Feb; 118(5):153-6. PubMed ID: 436143
    [No Abstract]   [Full Text] [Related]  

  • 40. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.